70 related articles for article (PubMed ID: 8344648)
1. Octreotide treatment does not improve impaired glucose uptake in cirrhosis.
Shmueli E; Orskov H; Alberti KG; Record CO
Horm Metab Res; 1993 Jun; 25(6):317-20. PubMed ID: 8344648
[TBL] [Abstract][Full Text] [Related]
2. Normal splanchnic but impaired peripheral insulin-stimulated glucose uptake in cirrhosis.
Shmueli E; Walker M; Alberti G; Record CO
Hepatology; 1993 Jul; 18(1):86-95. PubMed ID: 8100799
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone, insulin-like growth factor-1 and insulin resistance in cirrhosis.
Shmueli E; Stewart M; Alberti KG; Record CO
Hepatology; 1994 Feb; 19(2):322-8. PubMed ID: 7904978
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity.
Petrides AS; Stanley T; Matthews DE; Vogt C; Bush AJ; Lambeth H
Hepatology; 1998 Jul; 28(1):141-9. PubMed ID: 9657106
[TBL] [Abstract][Full Text] [Related]
5. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
6. Normalisation of insulin-like growth factor-I does not improve insulin action in cirrhosis.
Nielsen MF; Aagaard NK; Grøfte T; Frystyk J; Greisen J; Christiansen JS; Holland-Fischer P; Vilstrup H
Liver Int; 2011 Nov; 31(10):1511-8. PubMed ID: 21967317
[TBL] [Abstract][Full Text] [Related]
7. Glucose resistance contributes to diabetes mellitus in cirrhosis.
Petrides AS; Schulze-Berge D; Vogt C; Matthews DE; Strohmeyer G
Hepatology; 1993 Aug; 18(2):284-91. PubMed ID: 8340056
[TBL] [Abstract][Full Text] [Related]
8. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
Tietge UJ; Selberg O; Kreter A; Bahr MJ; Pirlich M; Burchert W; Müller MJ; Manns MP; Böker KH
Liver Transpl; 2004 Aug; 10(8):1030-40. PubMed ID: 15390330
[TBL] [Abstract][Full Text] [Related]
9. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
Kiwanuka E; Barazzoni R; Tessari P
Diabetes Nutr Metab; 2001 Dec; 14(6):315-24. PubMed ID: 11853363
[TBL] [Abstract][Full Text] [Related]
10. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
Keller U; Müller R; Berger W
Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
[TBL] [Abstract][Full Text] [Related]
11. Effects of mild-to-moderate hyperglycaemia per se on glucose production and uptake in the elderly.
Paolisso G; Marrazzo G; de Riu S; Sgambato S; Varricchio M; d'Onofrio F; Lefèbvre P
Eur J Med; 1992 Apr; 1(1):6-12. PubMed ID: 1341981
[TBL] [Abstract][Full Text] [Related]
12. Decreased leg glucose uptake during exercise contributes to the hyperglycaemic effect of octreotide.
Hovind P; Simonsen L; Bülow J
Clin Physiol Funct Imaging; 2010 Mar; 30(2):141-5. PubMed ID: 20132129
[TBL] [Abstract][Full Text] [Related]
13. [Study of insulin resistance in cirrhosis by the hyperinsulin euglycemia clamp].
Vetter D; Thonnet L; Doffoël M; Reville M; Winiszewski P; Blickle JF; Pinget M; Bockel R
Gastroenterol Clin Biol; 1988 May; 12(5):473-7. PubMed ID: 3042504
[TBL] [Abstract][Full Text] [Related]
14. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.
Vestergaard H; Bjørbaek C; Hansen T; Larsen FS; Granner DK; Pedersen O
J Clin Invest; 1995 Dec; 96(6):2639-45. PubMed ID: 8675629
[TBL] [Abstract][Full Text] [Related]
15. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
16. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
Kruszynska YT; Olefsky JM; Frias JP
Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
[TBL] [Abstract][Full Text] [Related]
17. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
18. Glucose turnover in compensated hepatic cirrhosis.
Piniewska DM; McCulloch AJ; Bramble MG; Taylor R; Record CO; Alberti KG
Horm Metab Res; 1986 Dec; 18(12):834-7. PubMed ID: 3817749
[TBL] [Abstract][Full Text] [Related]
19. Effects of octreotide on serum insulin-like growth factor I and insulin-like growth factor binding proteins in patients with cirrhosis.
Ottesen LH; Frystyk J; Kiszka-Kanowitz M; Grønbaek H; Bendtsen F; Flyvbjerg A
Scand J Clin Lab Invest; 2002; 62(1):39-47. PubMed ID: 12002412
[TBL] [Abstract][Full Text] [Related]
20. Hyperinsulinaemia and insulin resistance of cirrhosis: the importance of insulin hypersecretion.
Proietto J; Dudley FJ; Aitken P; Alford FP
Clin Endocrinol (Oxf); 1984 Dec; 21(6):657-65. PubMed ID: 6391746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
